Equities

Joint Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
JYNT:NAQ

Joint Corp

Actions
Health CareHealth Care Providers
  • Price (USD)8.92
  • Today's Change0.24 / 2.76%
  • Shares traded51.69k
  • 1 Year change-22.64%
  • Beta1.3392
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Joint Corp grew revenues 10.47% from 46.98m to 51.90m while net income improved from a loss of 9.75m to a smaller loss of 8.53m.
Gross margin78.84%
Net profit margin7.73%
Operating margin5.49%
Return on assets4.12%
Return on equity14.24%
Return on investment7.92%
More ▼

Cash flow in USDView more

In 2024, Joint Corp increased its cash reserves by 35.30%, or 6.78m. The company earned 9.42m from its operations for a Cash Flow Margin of 18.14%. In addition the company used 631.55k on investing activities and also paid 2.00m in financing cash flows.
Cash flow per share0.3226
Price/Cash flow per share27.01
Book value per share1.50
Tangible book value per share1.50
More ▼

Balance sheet in USDView more

Joint Corp uses little or no debt in its capital structure.
Current ratio1.83
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 85.95%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
120.97
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.